Zai Lab (ZLAB) EBITDA Margin (2019 - 2026)
Zai Lab's EBITDA Margin came in at -68.02% for Q2 2026, down 21.50 percentage points from -46.52% a year earlier and down 2.33 percentage points from the prior quarter.
Powered by 
Analysis
Zai Lab (ZLAB) EBITDA Margin (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Zai Lab reported EBITDA Margin of -55.20%, down 0.53 percentage points year-over-year; for FY2025, it came in at -46.60%, up 21.14 percentage points from FY2024.
- EBITDA Margin has increased in each of the last seven years, with a five-year change of +560.37 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -67.74% in FY2024 (+66.32 pp), -134.05% in FY2023 (+50.16 pp), -184.21% in FY2022 (+296.40 pp) and -480.61% in FY2021 (+126.36 pp).
- The Q2 2026 figure represents the lowest quarterly EBITDA Margin since Q2 2024.
- Year-over-year, EBITDA Margin increased in six of the last eight quarters, with an average year-over-year change of +28.60 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q1 2022 (a gain of 956.03 percentage points), and the weakest in Q4 2023 (a drop of 32.58 percentage points).
- Business Quant data shows ZLAB's EBITDA Margin at -65.70% (Q1 2026), -51.33% (Q4 2025) and -38.69% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.21 Bn | 1,100.80 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 616.27 Bn | 534.80 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 500.10 Bn | 473.21 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 366.86 Bn | 321.23 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.53 Bn | 235.22 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 234.99 Bn | 190.39 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 190.14 Bn | 164.34 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 169.63 Bn | 116.28 Bn | 10.94 Bn | 39.16% |
| 10 | Zai Lab | 2.73 Bn | 42.08 Mn | 58.15 Mn | -68.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -68.02% |
| Mar 31, 2026 | -65.70% |
| Dec 31, 2025 | -51.33% |
| Sep 30, 2025 | -38.62% |
| Jun 30, 2025 | -46.42% |
| Mar 31, 2025 | -49.63% |
| Dec 31, 2024 | -59.47% |
| Sep 30, 2024 | -63.54% |
| Jun 30, 2024 | -72.76% |
| Mar 31, 2024 | -76.42% |
| Dec 31, 2023 | -184.60% |
| Sep 30, 2023 | -117.95% |
| Jun 30, 2023 | -127.07% |
| Mar 31, 2023 | -106.48% |
| Dec 31, 2022 | -152.02% |
| Sep 30, 2022 | -219.60% |
| Jun 30, 2022 | -201.04% |
| Mar 31, 2022 | -166.40% |
| Dec 31, 2021 | -494.32% |
| Sep 30, 2021 | -189.24% |
API Access
Zai Lab EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZLAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ZLAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZLAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();